Overview
Galvus Met Tablet combines two antidiabetic agents: Vildagliptin (a DPP-4 inhibitor) and Metformin (a biguanide). This dual-action formulation is designed for patients with type 2 diabetes mellitus who require better glycemic control than achieved with monotherapy. Vildagliptin enhances insulin secretion and suppresses glucagon production, while Metformin improves insulin sensitivity and reduces glucose production in the liver.





